Pan-Coronavirus Therapy - viral genome disruption with Cas13

Written by Dr. Martin Andresen on 29 April 2021.

Pan-Coronavirus Therapy

Pan-Coronavirus Therapy using a Cas13-guideRNA system. The antiviral effect is based on an Cas13-guideRNA-AAV vector with up to five guideRNAs, which target and disrupt the genome of the Coronavirus - blocking viral replication. A therapeutic effect was proven in vivo in the SARS-CoV2 Hamster Model.